ADA/EASD statement on improving clinical value and use of CGM devices


eMediNexus    24 November 2017

A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group has published recommendations for systemic improvements in clinical use and regulatory pre and postmarketing handling of continuous glucose monitoring CGM devices to improve their safety and efficacy in achieving its potential to improve quality of life and health outcomes for more people with diabetes in the December 2017 issue of Diabetes Care.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.